This Combined Synopsis/Solicitation opportunity from Department Of Health And Human Services was posted on June 11, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
NOI -Illumina Infinium Methylation Screening Array
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, Office of the Director, Office of Acquisitions, is issuing a non-competitive Notice of Intent for a firm-fixed-price purchase order to acquire twenty Infinium Methylation Screening Array-48 Kits, catalog number 20112611, exclusively from Illumina, Inc., under FAR Subpart 12.6 and authority provided by FAR 6.302-3(a)(2)(ii) and 41 U.S.C. 1901. This procurement is conducted without full and open competition because Illumina is the sole manufacturer of the proprietary BeadChip-based methylation array technology, which is patent-protected and incompatible with any alternative products; it is also the only platform compatible with existing Illumina iScan and Infinium Automated Pipetting Systems installed at the NIA Laboratory of Neurogenetics. The requirement supports the NHLBI Division of Intramural Research’s epigenome-wide association study of DNA methylation patterns and cardiovascular disease mortality risk using excess biospecimens from the NCI PLCO Cancer Screening Trial. Responses must be submitted electronically by 9:00 AM EDT on June 18, 2026, to the designated point of contact, referencing solicitation number 75N98026Q00600, and must include a completed FAR 52.212-3, Unique Entity Identifier, Taxpayer Identification Number, business size certification, and active SAM registration. The solicitation requires detailed pricing information including unit and list price, shipping and handling costs, prompt payment discounts, F.O.B. point, delivery timeframe, and product specifications, with evaluation based on price, technical capability to supply the exact brand-name product, and other best value factors such as warranty and past performance. The contract will be awarded to the responsible offeror whose quotation provides the best value, and delivery is required by December 31, 2026, under DAP terms with FOB destination. Invoicing must be processed through the Invoicing Processing Platform and must reflect a three-way match and exact alignment to the purchase order line item. The NAICS code is 325413, the small business size standard is 1,250 employees, and this requirement is not set aside for small business. The contract will be governed by FAR and HHSAR clauses in effect through February 2026, including those related to SAM and CG
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
(ii) The solicitation number is 75N98026Q00600. This solicitation is issued as a Notice of Intent (NOI) for a non-competitive combined synopsis/solicitation to award a contract or purchase order without providing for full and open competition (brand-name).
This acquisition is conducted under the authority of FAR 12.603, Streamlined Solicitation for Commercial Products or Commercial Services, and is not expected to exceed the simplified acquisition threshold. Additional authority includes 41 U.S.C. 1901 and FAR 6.302-3(a)(2)(ii).
The National Institutes of Health (NIH), Office of the Director, Office of Acquisitions, intends to negotiate and award a firm-fixed-price purchase order on a non-competitive basis to Illumina, Inc., 5200 Illumina Way, San Diego, CA 92122 for twenty (20) Infinium Methylation Screening Array-48 Kits (Catalog No. 20112611) in support of the NHLBI Division of Intramural Research, Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LoGICO). Illumina is the sole manufacturer and source of the Infinium Methylation Screening Array, a proprietary BeadChip product protected by patents and trade secrets, and the only methylation array compatible with the Illumina iScan System and Infinium Automated Pipetting System with ILASS already installed at the NIA Laboratory of Neurogenetics where the assays will be performed. No other manufacturer produces a functionally equivalent product, and Illumina has certified in writing that it has not authorized any third-party intermediary to provide the Illumina products required for this transaction (Quotation No. 4791799).
(iii) The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2026-01, effective 03/13/2026.
(iv) The associated NAICS code is 325413 ¿ In-Vitro Diagnostic Substance Manufacturing, and the small business size standard is 1,250 employees. This requirement is not set aside for small business.
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
